Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| No statute on record | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RYAN, DOUGLAS CHARLES | 1 | 40.0% | +48.9% |
| SISSON, BRADLEY L | 1 | 19.6% | +21.0% |
| KIM, SEONG JONG | 1 | — | — |
| LU, CHENG | 1 | 54.1% | +67.9% |
| VANN-OJUEKAIYE, KENDRA RAYCHELL | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18245589 | CHEMICAL COMPOSITIONS AND METHODS OF USING THE SAME | SISSON, BRADLEY L | 66d overdue |
| 18010873 | COMPOSITIONS AND METHODS FOR IN SITU SINGLE CELL ANALYSIS USING ENZYMATIC NUCLEIC ACID EXTENSION | VANN-OJUEKAIYE, KENDRA RAYCHELL | 9d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18245589 | CHEMICAL COMPOSITIONS AND METHODS OF USING THE SAME | SISSON, BRADLEY L | 66d overdue |
| 18163810 | OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP | LU, CHENG | 32d overdue |
| 18435438 | ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES | RYAN, DOUGLAS CHARLES | 3d overdue |
| Art Unit | Apps |
|---|---|
| 1682 | 2 |
| 1635 | 1 |
| 1621 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18435438 | ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES | RYAN, DOUGLAS CHARLES | 1635 | Other | Final Rejection | 3d overdue | Pending | Feb 07, 2024 |
| 18245589 | CHEMICAL COMPOSITIONS AND METHODS OF USING THE SAME | SISSON, BRADLEY L | 1682 | §103 | Non-Final OA | 66d overdue | Pending | Mar 16, 2023 |
| 18172771 | CHEMICAL COMPOSITIONS AND METHODS OF USE | KIM, SEONG JONG | 1621 | Other | Non-Final OA | 8d overdue | Pending | Feb 22, 2023 |
| 18163810 | OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP | LU, CHENG | 1642 | Other | Non-Final OA | 32d overdue | Pending | Feb 02, 2023 |
| 18010873 | COMPOSITIONS AND METHODS FOR IN SITU SINGLE CELL ANALYSIS USING ENZYMATIC NUCLEIC ACID EXTENSION | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103 | Final Rejection | 9d overdue | Pending | Dec 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial